This content is machine translated Renal failure Stop heart muscle thickening with medication Patients with chronic renal impairment often develop thickening of the heart muscle as their disease progresses. The danger of left ventricular hypertrophy is a significant increase in the risk of…
View Post 5 min This content is machine translated Pollen allergy Specific subcutaneous immunotherapy – What’s new? Specific immunotherapy (SIT) is the only disease-modifying and curative form of therapy for the treatment of immediate-type allergies. In contrast to symptomatic pharmacological therapies, SIT pursues the goal of sustained…
View Post 4 min This content is machine translated Moderate to severe atopic dermatitis JAK inhibitor upadacitinib a clear winner in comparative study with dupilumab The development of innovative drugs for the treatment of atopic dermatitis (AD) is increasingly focused on targeted therapies that selectively interfere with disease-causing signaling pathways [1]. That the Janus kinase…
View Post 16 min This content is machine translated Type 2 diabetes The cardiovascular diabetic patient – an interdisciplinary challenge A patient with type 2 diabetes is 2-3 times more likely to have a myocardial infarction or stroke than people without diabetes. Cardiovascular disease accounts for up to 50% of… CME-Test
View Post 5 min This content is machine translated Rosacea Effective treatment through combination of different active ingredients The characteristic rosacea symptoms often overlap, so drug therapy should be tailored to the individual symptomatology. This is one of the Key Messages of the current ROSCO recommendations. Combination therapies…
View Post 6 min This content is machine translated Lymphoma of the skin What’s new? Often, cutaneous lymphomas receive little attention. And yet, a lot has happened in recent years. Thus, innovative treatment options are also emerging for these rare conditions through new therapeutic options…
View Post 5 min This content is machine translated Osteoporosis Management Match sequential long-term treatment to individual fracture risk According to guideline recommendations, individualized long-term measures must be adapted to the personal risk profile and disease activity. The overriding treatment goal is the best possible reduction of future fracture risk. To…
View Post 2 min This content is machine translated Leukemic cutaneous T-cell lymphoma (L-CTCL) Sézary syndrome and mycosis fungoides: STAT5 as a therapeutic target? As the disease progresses, the tumor cells in leukemic variants of cutaneous T-cell lymphomas spread not only in the skin but also in the blood and lymph nodes. Although an…
View Post 4 min This content is machine translated Management of dyslipidemia Lipid-lowering agents for secondary prophylaxis also effective in elderly patients A recent meta-analysis published in the Lancet concluded that lipid lowering achieved comparable reductions in cardiovascular events in people over 75 years of age as in younger individuals. In elderly…
View Post 3 min This content is machine translated Spinal muscular atrophy Clinical experience speaks for individual therapy management Spinal muscular atrophy is a rare genetic disorder characterized by the loss of motor neurons in the spinal cord and lower brainstem. In the meantime, experts agree that therapy management must…
View Post 4 min This content is machine translated Granulomatous diseases - an update News and interesting facts about pathomechanisms and treatment Both infectious and noninfectious granulomatous dermatoses are very heterogeneous clinical pictures. Treatment is based on pathogenesis and is primarily anti-inflammatory, with corticosteroids still playing an important role. A new therapeutic…
